Cargando…
Oncolytic virotherapy for pediatric malignancies: future prospects
Pediatric solid tumors remain a major health concern, with nearly 16,000 children diagnosed each year. Of those, ~2,000 succumb to their disease, and survivors often suffer from lifelong disability secondary to toxic effects of current treatments. Countless multimodality treatment regimens are being...
Autores principales: | Waters, Alicia M, Friedman, Gregory K, Ring, Eric K, Beierle, Elizabeth A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4996251/ https://www.ncbi.nlm.nih.gov/pubmed/27579298 http://dx.doi.org/10.2147/OV.S96932 |
Ejemplares similares
-
Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2012) -
Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012) -
Newly Characterized Murine Undifferentiated Sarcoma Models Sensitive to Virotherapy with Oncolytic HSV-1 M002
por: Ring, Eric K., et al.
Publicado: (2017) -
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
por: Quinn, Colin H., et al.
Publicado: (2022) -
Combination strategies enhance oncolytic virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2017)